Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | 676,564 | reported | 21 Feb 2026 | tx 4+3,101,527−338,282 |
| Zura Bio Ltd | 162,060 | reported | 18 May 2023 | tx 1+162,060 |
| ARENA PHARMACEUTICALS INC | 5,000 | reported | 25 Nov 2020 | tx 7+35,500−29,599 |
| Ruthigen, Inc. | 1,700 | reported | 26 Jan 2023 | tx 4+68,800 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Feb 2026 | OTHER | Inhibikase Therapeutics, Inc. | 338,282 | 0.00 USD | |
| 05 Jan 2026 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 900,117 | 0.00 USD | deriv |
| 21 Feb 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 1,100,705 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | Zura Bio Ltd | 162,060 | 0.00 USD | |
| 26 Jan 2023 | GRANT_AWARD | Ruthigen, Inc. | 1,700 | 0.00 USD | deriv |
| 27 Jan 2022 | GRANT_AWARD | Ruthigen, Inc. | 22,100 | 0.00 USD | deriv |
| 28 Jan 2021 | GRANT_AWARD | Ruthigen, Inc. | 15,000 | 0.00 USD | deriv |
| 25 Nov 2020 | TAX_WITHHOLDING | ARENA PHARMACEUTICALS INC | 1,099 | 65.50 USD | |
| 25 Nov 2020 | EXERCISE | ARENA PHARMACEUTICALS INC | 2,500 | 0.00 USD | |
| 25 Nov 2020 | EXERCISE | ARENA PHARMACEUTICALS INC | 2,500 | 0.00 USD | deriv |
| 15 Jul 2020 | EXERCISE | ARENA PHARMACEUTICALS INC | 13,000 | 26.28 USD | |
| 15 Jul 2020 | SALE | ARENA PHARMACEUTICALS INC | 13,000 | 68.00 USD | |
| 15 Jul 2020 | EXERCISE | ARENA PHARMACEUTICALS INC | 13,000 | 0.00 USD | deriv |
| 23 Jun 2020 | GRANT_AWARD | Ruthigen, Inc. | 30,000 | 0.00 USD | deriv |
| 12 Jun 2020 | GRANT_AWARD | ARENA PHARMACEUTICALS INC | 20,000 | 0.00 USD | deriv |